CARDIOVASCULAR
hamburger
product photo
SHAPING THE FUTURE

The Endurity™ pacemaker offers exceptional longevity in a small device size and a physiologic physician-preferred shape enabling a smaller incision and pocket size.

SMALL

Designed for ease of implant, this 10 cc physician-preferred shape1 and size pacemaker can enable a smaller incision and pocket size. 

 

graphic showing the longevity, size, and warranty
SIMPLIFIED

Easy access to a comprehensive suite of diagnostic data simplifies patient management and saves valuable time during routine, in-clinic, follow-up visits.4

THERAPY ASSURANCE
  • Reduce unnecessary RV pacing with beat-by-beat ventricular support to optimize patient safety and support intrinsic heart rhythm; Ventricular Intrinsic Preference (VIP™) has been shown to reduce RV pacing and heart-failure hospitalization.5
  • Ensure patient safety while managing changing patient thresholds; verify capture on a beat-by-beat basis, keeping output as low as possible to maximize pacemaker longevity.
BUILDING COMPREHENSIVE CARDIAC ARRHYTHMIA MANAGEMENT

The Endurity™ pacemaker is part of our arrhythmia management portfolio. Our vision is to transform the treatment of cardiac arrhythmias by designing cost-effective technologies that improve outcomes. Read more about our approach to cardiac arrhythmia management

RESOURCES AND DOCUMENTATION

PRODUCT MANUAL (INSTRUCTIONS FOR USE)

REFERENCES

1. St. Jude Medical. Data on file, Report 60048640. Market Research Report: Pacemaker Size and Shape. 2012.
2. Dual-chamber model; A,V = 2,5 V @ 0,4 ms; 600 ohms; 100% DDD pacing @ 60 bpm; AutoCapture™ Pacing System OFF; SEGMs ON (10 years). Single-chamber model; A,V = 2,5 V @ 0,4 ms; 600 ohms; 100% VVI pacing @ 60 bpm; AutoCapture™ Pacing System OFF; SEGMs ON (15 years).
3. Single-chamber model; dual-chamber model warranty is 8 years; terms and conditions apply; refer to the warranty for details.
4. St. Jude Medical data on file, Report 60033898. Enhanced Merlin Reports Human Factors Engineering Validation.
5. Faulknier, B., & Richards, M. (2012, December). The association of the use of the ventricular intrinsic preference (VIP™) feature with heart failure hospitalization in pacemaker patients. Presented at the XV International Symposium on Progress in Clinical Pacing, Rome, Italy.

 

PREMIUM FEATURES

PHYSICIAN-PREFERRED SIZE AND SHAPE

Physician-preferred size and physiologic shape minimize pocket size.

AUTOCAPTURE™ PACING SYSTEM

This feature offers the maximum in threshold adaptability and patient safety with ventricular Beat-by-Beat™ capture confirmation. The AutoCapture pacing system automatically delivers a 5,0 V backup safety pulse when noncapture is detected, and it may be programmed to either a bipolar or unipolar configuration.

PROGRAMMABLE REAL-TIME ELECTROGRAM (EGM) WAVEFORM

Real-time electrogram (EGM) waveform, as well as the associated event markers that precede and follow a specific triggering event, can be programmed to automatically record up to 14 minutes of stored EGMs when encountering one or more programmable trigger options.

SPECIFIC FEATURES FOR OUR DUAL- AND SINGLE-CHAMBER MODELS

DUAL-CHAMBER

STATE-OF-THE-ART FEATURES
  • Complete automaticity (atrial and ventricular)
  • Ventricular Intrinsic Preference (VIP™) technology
  • AF Suppression™ algorithm and SenseAbility™ technology—designed to deliver optimal therapy for patients at implant and throughout their lives
LONGEVITY
  • Outstanding longevity provides 9.4 years of service life,3 which is supported by an 8-year warranty4
  • 6-month ERI-EOL interval

SINGLE-CHAMBER

STATE-OF-THE-ART FEATURES
  • Automaticity
  • Ventricular AutoCapture™ pacing system for ventricular implants
  • ACap™ Confirm, AF Suppression™ algorithm and AT/AF diagnostics for atrial implants, and SenseAbility™ technology—designed to deliver optimal therapy for patients at implant and throughout their lives
LONGEVITY
  • Outstanding longevity provides 14.4 years of service life,3 which is supported by a 10-year warranty4
  • 6-month ERI-EOL interval
BUILDING COMPREHENSIVE CARDIAC ARRHYTHMIA MANAGEMENT

The Endurity™ pacemaker is part of our arrhythmia management portfolio. Our vision is to transform the treatment of cardiac arrhythmias by designing cost-effective technologies that improve outcomes. Read more about our approach to cardiac arrhythmia management.

RESOURCES AND DOCUMENTATION

PRODUCT MANUAL (INSTRUCTIONS FOR USE)

REFERENCES

1. A,V = 2,5 V @ 0,4 ms; 500 ohms; 100% DDD pacing @ 60 bpm; AutoCapture™ Pacing System OFF; SEGMs ON.
2. Terms and conditions apply; refer to the warranty for details.
3. A,V = 2,5 V @ 0,4 ms; 500 ohms; 100% VVI pacing @ 60 bpm; AutoCapture™ Pacing System OFF; SEGMs ON.
4. Terms and conditions apply; refer to the warranty for details.

ENDURITY™

Single-Chamber Pacemaker

Contents: Cardiac pulse generator

ORDERING INFORMATION 

Reorder Number

PM1160

Dimensions (H x W x T, mm)

41 x 50 x 6

Weight (g)

19

Volume (cc)

9.7 (± 0.5)

Connector

IS-1


ENDURITY™

Dual-Chamber Pacemaker

Contents: Cardiac pulse generator

ORDERING INFORMATION 

Reorder Number

PM2160

Dimensions (H x W x T, mm)

41 x 50 x 6

Weight (g)

19

Volume (cc)

9.7 (± 0.5)

Connector

IS-1

SEE FULL PRODUCT DETAILS and any references for this product.

CUSTOMER
SERVICE

Our customer service experts can help with your
product orders or questions

a natural wonder of sandstone caves

OUR PRODUCTS

See our featured innovations and technologies, full product catalog and approach to disease state management.

INDICATIONS, SAFETY & WARNINGS

INDICATIONS, SAFETY & WARNINGS

Indications: Implantation is indicated in one or more of the following permanent conditions: syncope, presyncope, fatigue, disorientation due to arrhythmia/bradycardia or any combination of those symptoms. Rate-Modulated Pacing is indicated for patients with chronotropic incompetence, and for those who would benefit from increased stimulation rates concurrent with physical activity. Dual-Chamber Pacing is indicated for those patients exhibiting: sick sinus syndrome, chronic, symptomatic second- and third-degree AV block, recurrent Adams-Stokes syndrome, symptomatic bilateral bundle branch block when tachyarrhythmia and other causes have been ruled out. Atrial Pacing is indicated for patients with sinus node dysfunction and normal AV and intraventricular conduction systems. Ventricular Pacing is indicated for patients with significant bradycardia and normal sinus rhythm with only rare episodes of A-V block or sinus arrest, chronic atrial fibrillation, severe physical disability. AF Suppression algorithm is indicated for suppression of paroxysmal or persistent atrial fibrillation episodes in patients with one or more of the above pacing indications.

 

Contraindications: Dual-chamber pulse generators are contraindicated in patients with an implanted cardioverter-defibrillator. Rate-Adaptive Pacing may be inappropriate for patients who experience angina or other symptoms of myocardial dysfunction at higher sensor-driven rates. An appropriate Maximum Sensor Rate should be selected based on assessment of the highest stimulation rate tolerated by the patient. AF Suppression stimulation is not recommended in patients who cannot tolerate high atrial-rate stimulation. Dual-Chamber Pacing, though not contraindicated for patients with chronic atrial flutter, chronic atrial fibrillation or silent atria, may provide no benefit beyond that of single-chamber pacing in such patients.Single-Chamber Ventricular Demand Pacing is relatively contraindicated in patients who have demonstrated pacemaker syndrome, have retrograde VA conduction or suffer a drop in arterial blood pressure with the onset of ventricular pacing. Single-Chamber Atrial Pacing is relatively contraindicated in patients who have demonstrated compromise of AV conduction.

 

Potential Adverse Events: The following are potential complications associated with the use of any pacing system: arrhythmia, heart block, thrombosis, threshold elevation, valve damage, pneumothorax, myopotential sensing, vessel damage, air embolism, body rejection phenomena, cardiac tamponade or perforation, formation of fibrotic tissue/local tissue reaction, inability to interrogate or program a device because of programmer malfunction, infection, interruption of desired device function due to electrical interference, loss of desired pacing and/or sensing due to lead displacement, body reaction at electrode interface or lead malfunction (fracture or damage to insulation), loss of normal device function due to battery failure or component malfunction, device migration, pocket erosion or hematoma, pectoral muscle stimulation, phrenic nerve or diaphragmatic stimulation. The following, in addition to the above, are potential complications associated with the use of rate-modulated pacing systems: inappropriate, rapid pacing rates due to sensor failure or to the detection of signals other than patient activity, loss of activity-response due to sensor failure, palpitations with high-rate pacing.

 

Refer to the User’s Manual for detailed indications, contraindications, warnings, precautions and potential adverse events.

 

SJM-CV WEB-0718-0018

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.


The website that you have requested also may not be optimized for your screen size.

Do you wish to continue and exit this website?

true
accessibility
© 2016 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

accessibility

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.


The website that you have requested also may not be optimized for your screen size.

Do you wish to continue and exit this website?